Segui
Giuseppe Boriani
Giuseppe Boriani
Full Professor in Cardiology, Modena University Hospital, University of Modena and Reggio Emilia
Email verificata su unimore.it
Titolo
Citata da
Citata da
Anno
Heart disease and stroke statistics—2016 update: a report from the American Heart Association
D Mozaffarian, EJ Benjamin, AS Go, DK Arnett, MJ Blaha, M Cushman, ...
circulation 133 (4), e38-e360, 2016
62048*2016
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) The …
G Hindricks, T Potpara, N Dagres, E Arbelo, JJ Bax, ...
European heart journal 42 (5), 373-498, 2021
86632021
Edoxaban versus warfarin in patients with atrial fibrillation
RP Giugliano, CT Ruff, E Braunwald, SA Murphy, SD Wiviott, JL Halperin, ...
New England Journal of Medicine 369 (22), 2093-2104, 2013
58092013
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with …
Authors/Task Force Members, SG Priori, C Blomström-Lundqvist, ...
Ep Europace 17 (11), 1601-1687, 2015
52692015
2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of …
Authors/Task Force Members, M Brignole, A Auricchio, G Baron-Esquivias, ...
European heart journal 34 (29), 2281-2329, 2013
37262013
The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
J Steffel, P Verhamme, TS Potpara, P Albaladejo, M Antz, L Desteghe, ...
European heart journal 39 (16), 1330-1393, 2018
31232018
European Society of Cardiology: cardiovascular disease statistics 2019
A Timmis, N Townsend, CP Gale, A Torbica, M Lettino, SE Petersen, ...
European heart journal 41 (1), 12-85, 2020
25272020
Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation
H Heidbuchel, P Verhamme, M Alings, M Antz, HC Diener, W Hacke, ...
Ep Europace 17 (10), 1467-1507, 2015
17462015
2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: Developed by the Task Force on cardiac pacing and cardiac resynchronization therapy of the European …
M Glikson, JC Nielsen, MB Kronborg, Y Michowitz, A Auricchio, ...
EP Europace 24 (1), 71-164, 2022
15522022
Efficacy of implantable cardioverter–defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy
BJ Maron, WK Shen, MS Link, AE Epstein, AK Almquist, JP Daubert, ...
New England Journal of Medicine 342 (6), 365-373, 2000
12432000
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology …
AR Lyon, T López-Fernández, LS Couch, R Asteggiano, MC Aznar, ...
European Heart Journal-Cardiovascular Imaging 23 (10), e333-e465, 2022
11372022
Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy
BJ Maron, P Spirito, WK Shen, TS Haas, F Formisano, MS Link, ...
Jama 298 (4), 405-412, 2007
9252007
Antithrombotic therapy for atrial fibrillation: CHEST guideline and expert panel report
GYH Lip, A Banerjee, G Boriani, C en Chiang, R Fargo, B Freedman, ...
Chest 154 (5), 1121-1201, 2018
8742018
Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a …
Task Force Members, GYH Lip, S Windecker, K Huber, P Kirchhof, ...
European heart journal 35 (45), 3155-3179, 2014
6752014
Screening for atrial fibrillation: a report of the AF-SCREEN International Collaboration
B Freedman, J Camm, H Calkins, JS Healey, M Rosenqvist, J Wang, ...
Circulation 135 (19), 1851-1867, 2017
5972017
Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial
P Ponikowski, BA Kirwan, SD Anker, T McDonagh, M Dorobantu, ...
The Lancet 396 (10266), 1895-1904, 2020
5632020
2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing
BL Wilkoff, L Fauchier, MK Stiles, CA Morillo, SM Al-Khatib, J Almendral, ...
EP Europace 18 (2), 159-183, 2016
4642016
Presence and duration of atrial fibrillation detected by continuous monitoring: crucial implications for the risk of thromboembolic events
GL Botto, L Padeletti, M Santini, A Capucci, M Gulizia, F Zolezzi, S Favale, ...
Journal of cardiovascular electrophysiology 20 (3), 241-248, 2009
4612009
Device-detected atrial fibrillation and risk for stroke: an analysis of> 10 000 patients from the SOS AF project (Stroke preventiOn Strategies based on Atrial Fibrillation …
G Boriani, TV Glotzer, M Santini, TM West, M De Melis, M Sepsi, ...
European heart journal 35 (8), 508-516, 2014
4582014
Monitored atrial fibrillation duration predicts arterial embolic events in patients suffering from bradycardia and atrial fibrillation implanted with antitachycardia pacemakers
A Capucci, M Santini, L Padeletti, M Gulizia, GL Botto, G Boriani, R Ricci, ...
Journal of the American College of Cardiology 46 (10), 1913-1920, 2005
4442005
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20